CPT® Code 81025

Last Updated: February 2026 | Verified for 2026 AMA, CPT & CMS Guidelines

Quick Reference: CPT 81025 (Urine Pregnancy Test, Visual Method)

• What 81025 means: A urine pregnancy test performed by visual color comparison using a test device/kit, with results read and documented by clinical/lab staff. It represents the test performance and interpretation at the point of care -- not an E/M service.
• CLIA-waived in routine office workflows: 81025 is commonly performed as a CLIA-waived point-of-care test; the site performing it must hold an appropriate CLIA certificate (typically a Certificate of Waiver) and follow waived testing requirements.
• CLIA number is a frequent claim requirement: Medicare and many payers require the performing laboratory's CLIA certificate number on the claim for CLIA-waived tests performed in-office. Missing CLIA data is a common avoidable denial cause.
• Modifier QW is generally not required for 81025: CMS guidance and Medicare contractor education materials list 81025 among common waived tests that do not require the QW modifier for waived recognition. Always follow payer-specific edits, but do not add QW reflexively.
• Bill only when the test is actually performed by the practice: A patient-reported home pregnancy test result is not the same as a provider-performed point-of-care test. To bill 81025, the practice must perform and document the test and result.
• Common high-yield use case: Pregnancy testing before contraception initiation or LARC/IUD workflows is a frequent, defensible indication when documented and linked to appropriate diagnosis coding.
• Preventive coverage can vary: Some commercial preventive policies explicitly allow pregnancy testing (81025) in wellness contexts; coverage and coding expectations depend on the plan's preventive services rules.

CPT 81025 (urine pregnancy test, visual method) is a high-volume point-of-care laboratory service used across primary care, urgent care, OB/GYN, and procedure settings. Payment and audit risk is usually not about whether pregnancy testing is clinically reasonable, it is about billing mechanics and documentation integrity.

The most common preventable failures are:

• missing CLIA information on claims for waived testing,
• adding QW incorrectly or inconsistently when a payer does not require it for 81025
• billing 81025 when the test was not actually performed by the billing entity, and
• using vague diagnosis coding that does not clearly communicate medical necessity for the test in that encounter.

1. Clinical Definition and Procedure Scope

CPT 81025 describes a urine pregnancy test performed using a method that is interpreted by visual color comparison. Operationally, the service is typically performed with a point-of-care test device (strip, cassette, or card format) designed to detect human chorionic gonadotropin (hCG) in urine. The code represents the laboratory testing service performed and read by clinical or laboratory personnel, with the result entered into the medical record.

1.1 What 81025 includes

• Performance of the urine pregnancy test using an appropriate test kit/device.
• Reading/interpreting the result (visual comparison method) and recording it.
• Routine testing workflow expected for a point-of-care test (specimen handling consistent with the kit instructions and the site's CLIA-waived processes).

1.2 What 81025 does not include

• E/M services: History, exam, and medical decision-making are billed separately when medically necessary and documented.
• Confirmatory or alternate specimen testing: Serum pregnancy tests (qualitative or quantitative) are different services and are coded separately using the appropriate CPT code family.
• Patient self-testing: A home pregnancy test result reported by the patient is not the same as a provider-performed test. To bill 81025, the practice must actually perform and document the test.

Practical boundary: If the clinical record only documents "patient reports positive home test" and the clinic does not perform a point-of-care test, billing 81025 is typically not supportable because the billed service did not occur at the billing entity.

2. CLIA Waiver Status, Site Requirements, and Claim Submission

Pregnancy testing by point-of-care urine methods is commonly performed under CLIA-waived conditions. The CLIA waived framework is operationally important because it drives two reimbursement realities: (1) the site must be appropriately certified to perform waived tests, and (2) claims frequently require CLIA identifiers to process payment cleanly.

2.1 CLIA-waived status and why it matters

The CDC maintains a list of tests granted waived status under CLIA. In practice, clinics and urgent care sites performing waived testing should maintain CLIA documentation, adhere to manufacturer instructions, and follow waived testing policies appropriate to the site.

2.2 Certificate of Waiver and operational controls

A clinic performing 81025 as a point-of-care test typically operates under a CLIA Certificate of Waiver. For compliance and defensibility, the following operational controls are high-yield:

• CLIA certificate is active and corresponds to the performing location.
• Waived testing procedures exist (specimen handling, training, quality checks as required by site policy).
• Result documentation is standardized (structured EHR field preferred over free-text).

2.3 Medicare claim submission: CLIA number and the QW modifier

Medicare contractor education emphasizes that CLIA-waived testing often requires submission of the CLIA certificate number on the claim; missing CLIA information is a recurring denial driver.

Separately, not all waived tests require modifier QW. CMS guidance (MLN Matters) and Medicare contractor materials list 81025 among common waived tests that do not require QW to be recognized as waived.

Claims hygiene rule: For 81025, do not add QW automatically. Follow payer edits, but align with CMS/contractor guidance that 81025 is among waived tests commonly processed without QW.

2.4 "Who performed the test?" must match "who billed the test"

For in-office testing, the billing entity should be the entity that actually performed the test at the certified site. If the test is performed at a different location (for example, an external laboratory), billing should follow the performing/billing relationships and payer rules. At minimum, the record should make it clear:

• That the test was performed in the clinic/office/urgent care site.
• That the test result was read and recorded by staff under the site's testing process.
• Which location performed the test (important for multi-site organizations).

3. Medicare and Commercial Coverage Considerations

Coverage for CPT 81025 is generally straightforward when it is ordered for a clear clinical purpose, performed at a CLIA-appropriate site, and documented with an appropriate diagnosis.

3.1 Medicare Part B coverage (typical framework)

In Medicare workflows, 81025 is processed as a laboratory service when medically necessary. Coverage is not "preventive by default"; rather, it is typically tied to a clinical indication (symptoms, treatment planning, pre-procedure clearance, medication safety, imaging decisions). The strongest Medicare defensibility pattern is:

• Order documented (or standing order protocol documented where applicable).
• Indication documented (why pregnancy status changes management).
• Result documented and acted upon as clinically appropriate.
• CLIA certificate number present on claims when required by payer processing.

3.2 Commercial payers: preventive policies and variability

Commercial coverage may treat pregnancy testing as diagnostic or as preventive depending on plan design and the clinical context. Some preventive service policies explicitly allow pregnancy testing as part of wellness care. For example, Cigna's preventive services policy lists pregnancy testing (CPT 81025) within preventive care contexts.

Payer realism: Even if a plan includes pregnancy testing in preventive benefits, claims still commonly fail for operational reasons (missing documentation elements, mismatched diagnosis pointers, or inconsistent billing across sites). Use the plan's preventive rules where applicable, but keep the documentation and diagnosis logic clinically explicit.

3.3 Same-day E/M and modifier 25 (when relevant)

Because 81025 is a laboratory CPT code, it is generally reported separately from an E/M service when both are performed and supported. Modifier 25 is not applied to the laboratory test code. If an E/M is billed on the same date, modifier 25 is considered only when the E/M is significant and separately identifiable from the work inherent in performing the test and communicating the result. This is an E/M documentation issue: the record must show that the visit involved meaningful evaluation/management beyond the test itself.

4. Documentation Standards and Audit-Proofing

Documentation is the main determinant of defensibility for 81025. Payers and auditors typically look for: (1) why the test was needed, (2) that the test was actually performed at the billing site, and (3) the result and how it was used in clinical decision-making.

4.1 Minimum documentation elements

A defensible record for CPT 81025 should include:

• Clinical indication: the reason pregnancy status needed confirmation/exclusion (symptom evaluation, pre-procedure, medication safety, contraception initiation, etc.).
• Order or standing protocol: provider order or protocol-based testing process documented.
• Specimen and method: urine sample collected and point-of-care pregnancy test performed (visual method implied by code selection, but documentation should still be clear).
• Result: positive/negative (and if available, date/time recorded).
• Performer and review: staff member who performed the test and provider review/acknowledgment when required by workflow policy.

4.2 Indications that are commonly defensible

Common clinical use cases include:

• Missed menstrual period, irregular menses, amenorrhea.
• Pelvic/abdominal pain or abnormal uterine bleeding (pregnancy must be considered in differential).
• Pre-procedure clearance when pregnancy status affects consent, imaging choices, anesthesia planning, or medication selection.
• Contraception initiation or LARC/IUD workflows where pregnancy must be reasonably excluded prior to prescribing/insertion.
• Symptoms suggestive of pregnancy (nausea, breast tenderness, fatigue) when confirmation changes care planning.

4.3 LARC / contraception workflows (common high-volume scenario)

Coding and operational tools used in contraception programs often include CPT 81025 to document office pregnancy testing, including workflows that link to pregnancy test result coding (e.g., negative test) and contraception management.

Workflow risk: In contraception/LARC settings, the highest denial risk is not the clinical logic -- it is missing documentation that the clinic performed the test (and captured the result) and missing claim-level CLIA data where required.

5. Diagnosis Coding for Medical Necessity (ICD-10-CM)

Diagnosis coding is how the claim communicates medical necessity. For 81025, the best practice is to link the pregnancy test to the reason it was ordered and, when appropriate, to document the test result diagnosis coding used by the organization.

5.1 Common ICD-10 patterns (examples)

The following categories are commonly used to support pregnancy testing, depending on the scenario:

• Z32.0x -- Encounter for pregnancy test (with result noted by subtype). This is often the most direct coding when the visit is specifically for pregnancy testing.
• Z30.x -- Contraceptive management (initiation/prescription/insertion counseling contexts).
• Z01.410--Z01.419 -- Routine gynecological examination (with/without abnormal findings) where pregnancy testing may be performed depending on clinical context.
• N91.x--N92.x -- Menstrual irregularities / amenorrhea / abnormal bleeding.
• R10.x -- Abdominal/pelvic pain and related symptom evaluation.
• Z01.818 -- Other specified pre-procedural/special examinations when pregnancy status is required for clearance.

5.2 Diagnosis selection principle

Choose the diagnosis that best represents why the test was needed (symptom, management decision, pre-procedure clearance, contraception plan). Avoid overly generic screening codes unless the payer's preventive policy explicitly supports them for pregnancy testing and the encounter truly is preventive.

6. Comparison Table: 81025 vs Related Pregnancy Testing Codes

7. Real-World Clinical Scenarios and Coding Examples

Scenario 1: Urgent care pelvic pain -- pregnancy must be ruled out

Setting: Urgent care or primary care same-day visit. Clinical reason: Pelvic/abdominal pain in a patient of childbearing potential; pregnancy status changes imaging/medication decisions. Coding logic: Report the E/M service as supported and report 81025 for the in-office urine pregnancy test when performed and documented. Ensure the test result is recorded in the chart. Claim hygiene: Ensure CLIA certificate number is present when required by payer processing.

Scenario 2: Contraception initiation -- negative test required before prescribing

Setting: Family planning or primary care visit. Clinical reason: Patient requests initiation of contraception; pregnancy must be reasonably excluded prior to prescribing or initiating certain methods. Coding logic: Report 81025 when the clinic performs and documents the urine test; report the appropriate E/M or counseling service if medically necessary and documented as separately identifiable. Operational anchor: Contraception coding resources commonly include 81025 in LARC/contraception workflows, reinforcing its use when performed and documented in-office.

Scenario 3: Preventive/wellness context -- commercial preventive policy may apply

Setting: Well-woman or wellness exam with a commercial payer. Clinical reason: Pregnancy testing performed as part of a preventive services workflow (plan-dependent). Coding logic: Report 81025 only if performed and documented. Coverage depends on the plan's preventive services policy and diagnosis coding strategy. Some preventive policies explicitly allow pregnancy testing (81025) within preventive care services. Risk control: If the payer treats the test as diagnostic, ensure the record states the clinical indication rather than relying on a generic preventive framing.

Scenario 4: IUD/LARC visit -- pregnancy test performed before insertion workflow

Setting: OB/GYN or family planning clinic. Clinical reason: Pregnancy must be excluded prior to IUD insertion or certain LARC services (workflow- and guideline-driven). Coding logic: Report 81025 when the clinic performs the urine test and records the result; report the procedure and/or visit per documentation. Coding tools used in LARC programs commonly include 81025 as part of these office workflows.

Scenario 5: Denial prevention -- CLIA data missing on claim

Setting: Primary care office performing CLIA-waived tests. Problem: Claim denies because the CLIA certificate number is missing or mismatched to the performing site. Fix: Confirm the correct CLIA number for the performing location and ensure it is transmitted consistently on claims for waived tests. Medicare contractor guidance emphasizes correct CLIA claim submission and educates providers on waived test modifier rules (including that some tests, such as 81025, do not require QW).

Practical Checklist: "Audit-Ready" 81025 in 2026

• Test performed on-site: The clinic actually ran the urine test; not merely recorded a patient-reported home result.
• Indication documented: Why pregnancy status was needed for decision-making.
• Result documented: Positive/negative result recorded in a retrievable field or clear note.
• CLIA compliance: Performing site holds appropriate CLIA certification for waived testing; staff follow site procedures.
• Claim completeness: CLIA certificate number submitted when required; avoid reflexive QW use for 81025 unless a payer specifically requires it.
• Coverage awareness: If billing in a preventive context, confirm the plan's preventive services policy expectations and align diagnosis coding accordingly.